Nease R F, Owens D K
Department of Community and Family Medicine, Dartmouth Medical School, Hanover, New Hampshire 03756.
Med Decis Making. 1994 Oct-Dec;14(4):382-92. doi: 10.1177/0272989X9401400409.
Many clinical practice guidelines fail to account for the preferences of the individual patient. Approaches that seek to include the preferences of the individual patient in the decision-making process (e.g., interactive videodisks for patient education), however, may incur substantial incremental costs. Developers of clinical practice guidelines must therefore determine whether it is appropriate to make their guidelines flexible with regard to patient preferences. The authors present a formal method for determining the cost-effectiveness of incorporating the preferences of individual patients into clinical practice guidelines. Based on utilities assessed from 37 patients, they apply the method in the setting of mild hypertension. In this example, they estimate that the cost-effectiveness ratio for individualized utility assessment is $48,565 per quality-adjusted year of life, a ratio that compares favorably with other health interventions that are promoted actively. This approach, which can be applied to any clinical domain, offers a formal method for determining whether the incorporation of individual patient preferences is important clinically and is justified economically.
许多临床实践指南并未考虑个体患者的偏好。然而,试图将个体患者的偏好纳入决策过程的方法(例如,用于患者教育的交互式视频光盘)可能会产生大量额外成本。因此,临床实践指南的制定者必须确定使其指南在患者偏好方面具有灵活性是否合适。作者提出了一种正式方法,用于确定将个体患者的偏好纳入临床实践指南的成本效益。基于对37名患者评估的效用,他们在轻度高血压的背景下应用了该方法。在这个例子中,他们估计个性化效用评估的成本效益比为每质量调整生命年48,565美元,这一比率与其他积极推广的健康干预措施相比具有优势。这种方法可应用于任何临床领域,为确定纳入个体患者偏好是否在临床上重要且在经济上合理提供了一种正式方法。